Atlas Trials

A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma

Clinical trial NCT00002319 · COMPLETED

Trial details

NCT number
NCT00002319
Sponsor
Sequus Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Sarcoma, KaposiHIV Infections

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.